FAMICORD AG (V3V.DE) Stock Price, Forecast & Analysis
FRA:V3V • DE000A0BL849
V3V.DE Key Statistics, Chart & Performance
The current stock price of V3V.DE is 5.3 EUR. In the past month the price decreased by -8.62%. In the past year, price increased by 26.79%.
V3V.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to V3V.DE. When comparing the yearly performance of all stocks, V3V.DE is one of the better performing stocks in the market, outperforming 72.81% of all stocks.
V3V.DE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
V3V.DE Forecast & Estimates
7 analysts have analysed V3V.DE and the average price target is 7.65 EUR. This implies a price increase of 44.34% is expected in the next year compared to the current price of 5.3.
V3V.DE Ownership
V3V.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FRE | FRESENIUS SE & CO KGAA | 13.55 | 29.356B | ||
| 1FRE | FRESENIUS SE & CO KGAA | 13.08 | 28.173B | ||
| FME | FRESENIUS MEDICAL CARE AG | 9.74 | 24.271B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About V3V.DE
Company Profile
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. The company is headquartered in Leipzig, Sachsen and currently employs 771 full-time employees. The company went IPO on 2007-11-21. The firm is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected during the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. The cells also allow the growing of whole organs, such as the liver. On an average, one out of seven individuals, whose cells are sorted, receives autologous stem cell transplant by age of 70. The firm acts as a cord blood bank and is also engaged in research activities around regenerative medicine, including curing the consequences of strokes and heart attacks. The firm operates in Germany, Spain and Denmark.
Company Info
FAMICORD AG
Perlickstrasse 5
Leipzig SACHSEN DE
Employees: 783
Phone: 49341487925500
FAMICORD AG / V3V.DE FAQ
What does FAMICORD AG do?
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. The company is headquartered in Leipzig, Sachsen and currently employs 771 full-time employees. The company went IPO on 2007-11-21. The firm is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected during the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. The cells also allow the growing of whole organs, such as the liver. On an average, one out of seven individuals, whose cells are sorted, receives autologous stem cell transplant by age of 70. The firm acts as a cord blood bank and is also engaged in research activities around regenerative medicine, including curing the consequences of strokes and heart attacks. The firm operates in Germany, Spain and Denmark.
Can you provide the latest stock price for FAMICORD AG?
The current stock price of V3V.DE is 5.3 EUR. The price increased by 0.95% in the last trading session.
Does V3V stock pay dividends?
V3V.DE does not pay a dividend.
What is the ChartMill rating of FAMICORD AG stock?
V3V.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Where is FAMICORD AG (V3V.DE) stock traded?
V3V.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the market capitalization of V3V stock?
FAMICORD AG (V3V.DE) has a market capitalization of 93.49M EUR. This makes V3V.DE a Micro Cap stock.
What is the ownership structure of FAMICORD AG (V3V.DE)?
You can find the ownership structure of FAMICORD AG (V3V.DE) on the Ownership tab.